Kenta Misaki

Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Timing of Recombinant Herpes Zoster Virus Vaccination Administration and JAK Inhibitor Initiation in Rheumatoid Arthritis: A Multicenter, Open-Label, Randomized Comparative Study.

Timing of Recombinant Herpes Zoster Virus Vaccination Administration and JAK Inhibitor Initiation in Rheumatoid Arthritis: A Multicenter, Open-Label, Randomized Comparative Study.

Journal: Annals of internal medicine

Published: July 20, 2026

Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study).

Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study).

Journal: Drug discoveries & therapeutics

Published: April 26, 2026

Applying the consensus-based salivary glands ultrasound scoring system in lacrimal glands: results of a static image-based OMERACT reliability exercise.

Applying the consensus-based salivary glands ultrasound scoring system in lacrimal glands: results of a static image-based OMERACT reliability exercise.

Journal: Seminars in arthritis and rheumatism

Published: September 12, 2025

Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study.

Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study.

Journal: Modern rheumatology

Published: August 14, 2025

Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial.

Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial.

Journal: Arthritis research & therapy

Published: January 15, 2025

Optimal timing of recombinant herpes zoster virus vaccination for a JAK inhibitor treatment in rheumatoid arthritis: a multicentre, open-label, randomised comparative study (STOP-HZ study): study protocol.

Optimal timing of recombinant herpes zoster virus vaccination for a JAK inhibitor treatment in rheumatoid arthritis: a multicentre, open-label, randomised comparative study (STOP-HZ study): study protocol.

Journal: BMJ open

Published: November 17, 2024

Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI).

Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI).

Journal: Modern rheumatology

Published: February 29, 2024

Large-vessel vasculitis developed after use of long-acting granulocyte colony-stimulating factor in a patient with diffuse large B-cell lymphoma

Large-vessel vasculitis developed after use of long-acting granulocyte colony-stimulating factor in a patient with diffuse large B-cell lymphoma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 01, 2023

Pulmonary alveolar proteinosis during treatment of immune-mediated necrotizing myopathy.

Pulmonary alveolar proteinosis during treatment of immune-mediated necrotizing myopathy.

Journal: International journal of rheumatic diseases

Published: September 11, 2023

Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational 'ORIGAMI' study.

Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational 'ORIGAMI' study.

Journal: Modern rheumatology

Published: April 03, 2023

Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI).

Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI).

Journal: Modern rheumatology

Published: December 19, 2022

Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc subgroup analysis of the ORIGAMI study.

Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc subgroup analysis of the ORIGAMI study.

Journal: Modern rheumatology

Published: January 21, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026